These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 12790797)

  • 41. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors.
    Hermans E
    Pharmacol Ther; 2003 Jul; 99(1):25-44. PubMed ID: 12804697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localization of G-protein-coupled receptors in health and disease.
    Edwards SW; Tan CM; Limbird LE
    Trends Pharmacol Sci; 2000 Aug; 21(8):304-8. PubMed ID: 10918636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modelling receptor-controlled intracellular calcium oscillators.
    Cuthbertson KS; Chay TR
    Cell Calcium; 1991; 12(2-3):97-109. PubMed ID: 1647879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A boolean network modelling of receptor mosaics relevance of topology and cooperativity.
    Agnati LF; Guidolin D; Leo G; Fuxe K
    J Neural Transm (Vienna); 2007 Jan; 114(1):77-92. PubMed ID: 16955372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Receptor crosstalk. Implications for cardiovascular function, disease and therapy.
    Dzimiri N
    Eur J Biochem; 2002 Oct; 269(19):4713-30. PubMed ID: 12354102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell viability modulation through changes of Ca(2+)-dependent signalling pathways.
    Wójcik-Piotrowicz K; Kaszuba-Zwoińska J; Rokita E; Thor P
    Prog Biophys Mol Biol; 2016 May; 121(1):45-53. PubMed ID: 26777586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Receptors, G proteins, and integration of calcium signalling.
    Gudermann T; Bader M
    J Mol Med (Berl); 2015 Sep; 93(9):937-40. PubMed ID: 26293356
    [No Abstract]   [Full Text] [Related]  

  • 48. GPCRs come of age in San Diego.
    Crossley R
    Drug Discov Today; 2003 Jan; 8(1):19-20. PubMed ID: 12546986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Membrane organization in G-protein mechanisms.
    Neubig RR
    FASEB J; 1994 Sep; 8(12):939-46. PubMed ID: 8088459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ca-signaling G-protein-coupled receptors: a new site of local anesthetic action?
    Hollmann MW; Difazio CA; Durieux ME
    Reg Anesth Pain Med; 2001; 26(6):565-71. PubMed ID: 11707797
    [No Abstract]   [Full Text] [Related]  

  • 51. A summary and conclusions from the meeting.
    Marshall FH
    J Mol Neurosci; 2005; 26(2-3):295-8. PubMed ID: 16012203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium signaling is involved in diverse cellular processes in fungi.
    Roy A; Kumar A; Baruah D; Tamuli R
    Mycology; 2020 Jul; 12(1):10-24. PubMed ID: 33628605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development.
    Agnati LF; Tarakanov AO; Ferré S; Fuxe K; Guidolin D
    J Mol Neurosci; 2005; 26(2-3):193-208. PubMed ID: 16012193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modularized study of human calcium signalling pathway.
    Nayak L; De RK
    J Biosci; 2007 Aug; 32(5):1009-17. PubMed ID: 17914243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases.
    Natarajan K; Berk BC
    Methods Mol Biol; 2006; 332():51-77. PubMed ID: 16878685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial.
    Ciofoaia V; Chen W; Tarek BW; Gay M; Shivapurkar N; Smith JP
    Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coincident Regulation of PLC
    Sanchez GA; Jutkiewicz EM; Ingram S; Smrcka AV
    Mol Pharmacol; 2022 Dec; 102(6):269-279. PubMed ID: 36116788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis.
    Rabiee A; Gay MD; Shivapurkar N; Cao H; Nadella S; Smith CI; Lewis JH; Bansal S; Cheema A; Kwagyan J; Smith JP
    Clin Pharmacol Ther; 2022 Dec; 112(6):1271-1279. PubMed ID: 36087237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons.
    Pemberton K; Rosato M; Dedert C; DeLeon C; Arnatt C; Xu F
    eNeuro; 2022; 9(4):. PubMed ID: 35788105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome.
    Gay MD; Cao H; Shivapurkar N; Dakshanamurthy S; Kallakury B; Tucker RD; Kwagyan J; Smith JP
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.